BMC Medical Co., Ltd. (SHE:301367)
China flag China · Delayed Price · Currency is CNY
43.74
-1.85 (-4.06%)
At close: Sep 11, 2026

BMC Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,3781,158842.241,1191,413661.08
Other Revenue
0.841.361.243.012.621.42
1,3791,159843.481,1221,415662.5
Revenue Growth
37.15%37.46%-24.85%-20.70%113.64%18.20%
Cost of Revenue
642.61555.87449.31619.28828.15377.5
Gross Profit
735.96603.55394.17503.14587.22285
Selling, General & Admin
338.76256.16172.58142.35131.6895.52
Research & Development
143.27139.12124.62116.9872.8648.28
Other Operating Expenses
-36.12-17.43-2.76-23.5-19.3-9.51
Operating Expenses
445.79380.25297.2238.62189.01134.53
Operating Income
290.18223.3196.98264.51398.2150.47
Interest Expense
-1.53-4.97-2.85-1.36-0.46-0.2
Interest & Investment Income
44.1457.6162.3663.3620.0911.56
Currency Exchange Gain (Loss)
-14.41-10.974.51-0.411.98-3.67
Other Non Operating Income (Expenses)
-22.36-1.11-0.850.2-0.26-0.53
EBT Excluding Unusual Items
296.01263.87160.14326.31429.55157.64
Gain (Loss) on Sale of Investments
-27.39-7.8210.44---
Gain (Loss) on Sale of Assets
0.260.260.190.480.02-
Asset Writedown
-3.52-0.83-3.06-0.02--0.01
Other Unusual Items
2.045.898.427.275.526.24
Pretax Income
267.4261.36176.14334.03435.09163.86
Income Tax Expense
39.7530.117.5434.254.0618.18
Earnings From Continuing Operations
227.65231.26158.6299.83381.03145.68
Minority Interest in Earnings
-6.77-5.6-3.22-2.49-0.74-
Net Income
220.89225.66155.38297.34380.3145.68
Net Income to Common
220.89225.66155.38297.34380.3145.68
Net Income Growth
13.65%45.23%-47.74%-21.81%161.05%-36.07%
Shares Outstanding (Basic)
1241241251259994
Shares Outstanding (Diluted)
1241241251259994
Shares Change
0.01%-0.51%-0.29%26.33%5.67%-0.16%
EPS (Basic)
1.781.811.242.373.831.55
EPS (Diluted)
1.781.811.242.373.831.55
EPS Growth
13.64%45.97%-47.59%-38.11%147.04%-35.96%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
133.3197.94138.16126.98351.4694.38
Free Cash Flow Per Share
1.070.791.101.013.541.00
Dividend Per Share
0.4710.4710.2860.5101.020-
Dividend Growth
65.00%65.00%-44.00%-50.00%233.35%-
Gross Margin
53.39%52.06%46.73%44.83%41.49%43.02%
Operating Margin
21.05%19.26%11.50%23.57%28.13%22.71%
Profit Margin
16.02%19.46%18.42%26.49%26.87%21.99%
Free Cash Flow Margin
9.67%8.45%16.38%11.31%24.83%14.24%
EBITDA
303.14234.68109.53274.46403.85155.09
EBITDA Margin
21.99%20.24%12.98%24.45%28.53%23.41%
D&A For EBITDA
12.9711.3812.559.955.654.62
EBIT
290.18223.3196.98264.51398.2150.47
EBIT Margin
21.05%19.26%11.50%23.57%28.13%22.71%
Effective Tax Rate
14.87%11.52%9.96%10.24%12.42%11.09%
Revenue as Reported
615.581,159843.481,1221,415662.5
Advertising Expenses
---39.676.744.26